Flexible, rule-based dose escalation: The cohort-sequence design

por Li, Shuang, Xie, Xian-Jin, Heitjan, Daniel F.
Publicado 2020

Prevalence of Hepatitis C Virus Antibody in Patients With Sexually Transmitted Diseases Attending a Harrisburg, PA, STD Clinic

por Sautter, Robert L., Jones, Sharon, Weber, Daniel I., LeBar, William D., Heitjan, Daniel F., Kopreski, Mary Magdalene C., Curcio, Frederick D.
Publicado 1994

COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans

por Tsai, Shirling, Nguyen, Hang, Ebrahimi, Ramin, Barbosa, Monica R., Ramanan, Bala, Heitjan, Daniel F., Hastings, Jeffrey L., Modrall, J. Gregory, Jeon-Slaughter, Haekyung
Publicado 2021

Dietary flaxseed administered post thoracic radiation treatment improves survival and mitigates radiation-induced pneumonopathy in mice

por Christofidou-Solomidou, Melpo, Tyagi, Sonia, Tan, Kay-See, Hagan, Sarah, Pietrofesa, Ralph, Dukes, Floyd, Arguiri, Evguenia, Heitjan, Daniel F, Solomides, Charalambos C, Cengel, Keith A
Publicado 2011

Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer

por Pruitt, Sandi L., Gerber, David E., Zhu, Hong, Heitjan, Daniel F., Maddineni, Bhumika, Xiong, Danyi, Singal, Amit G., Tavakkoli, Anna, Halm, Ethan A., Murphy, Caitlin C.
Publicado 2021

Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking

por Tyndale, Rachel F., Zhu, Andy Z. X., George, Tony P., Cinciripini, Paul, Hawk, Larry W., Schnoll, Robert A., Swan, Gary E., Benowitz, Neal L., Heitjan, Daniel F., Lerman, Caryn
Publicado 2015

Survival of cancer survivors with a new pancreatic cancer diagnosis

por Pruitt, Sandi L., Tavakkoli, Anna, Zhu, Hong, Heitjan, Daniel F., Gerber, David E., Singal, Amit G., Halm, Ethan A., Beg, Muhammad Shaalan, Maddineni, Bhumika, Kansagra, Ankit J., Murphy, Caitlin C.
Publicado 2022

Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin

por Nath, Kavindra, Roman, Jeffrey, Nelson, David S., Guo, Lili, Lee, Seung-Cheol, Orlovskiy, Stepan, Muriuki, Kevin, Heitjan, Daniel F., Pickup, Stephen, Leeper, Dennis B., Blair, Ian A., Putt, Mary E., Glickson, Jerry D.
Publicado 2018

Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients

por Stevenson, James P, Kindler, Hedy L, Papasavvas, Emmanouil, Sun, Jing, Jacobs-Small, Mona, Hull, Jennifer, Schwed, Daniel, Ranganathan, Anjana, Newick, Kheng, Heitjan, Daniel F, Langer, Corey J, McPherson, John M, Montaner, Luis J, Albelda, Steven M
Publicado 2013

An Active Learning Approach for Rapid Characterization of Endothelial Cells in Human Tumors

por Padmanabhan, Raghav K., Somasundar, Vinay H., Griffith, Sandra D., Zhu, Jianliang, Samoyedny, Drew, Tan, Kay See, Hu, Jiahao, Liao, Xuejun, Carin, Lawrence, Yoon, Sam S., Flaherty, Keith T., DiPaola, Robert S., Heitjan, Daniel F., Lal, Priti, Feldman, Michael D., Roysam, Badrinath, Lee, William M. F.
Publicado 2014

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

por Rosenfeld, Myrna R, Ye, Xiaobu, Supko, Jeffrey G, Desideri, Serena, Grossman, Stuart A, Brem, Steven, Mikkelson, Tom, Wang, Daniel, Chang, Yunyoung C, Hu, Janice, McAfee, Quentin, Fisher, Joy, Troxel, Andrea B, Piao, Shengfu, Heitjan, Daniel F, Tan, Kay-See, Pontiggia, Laura, O’Dwyer, Peter J, Davis, Lisa E, Amaravadi, Ravi K
Publicado 2014

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

por Rangwala, Reshma, Leone, Robert, Chang, Yunyoung C, Fecher, Leslie A, Schuchter, Lynn M, Kramer, Amy, Tan, Kay-See, Heitjan, Daniel F, Rodgers, Glenda, Gallagher, Maryann, Piao, Shengfu, Troxel, Andrea B, Evans, Tracey L, DeMichele, Angela M, Nathanson, Katherine L, O’Dwyer, Peter J, Kaiser, Jonathon, Pontiggia, Laura, Davis, Lisa E, Amaravadi, Ravi K
Publicado 2014

Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

por Rangwala, Reshma, Chang, Yunyoung C, Hu, Janice, Algazy, Kenneth M, Evans, Tracey L, Fecher, Leslie A, Schuchter, Lynn M, Torigian, Drew A, Panosian, Jeffrey T, Troxel, Andrea B, Tan, Kay-See, Heitjan, Daniel F, DeMichele, Angela M, Vaughn, David J, Redlinger, Maryann, Alavi, Abass, Kaiser, Jonathon, Pontiggia, Laura, Davis, Lisa E, O’Dwyer, Peter J, Amaravadi, Ravi K
Publicado 2014